Solubilty and dissolution studies of antifungal drug:hydroxybutenyl-β-cyclodextrin complexes

Cellulose

Volumn 14, Issue 1, 2007, Pages 35-47

  Buchanan, Charles M ^a   Buchanan, Norma L ^a   Edgar, Kevin J ^a   Ramsey, Michael G ^a  

^a EASTMAN CHEMICAL COMPANY   (United States)

Author keywords

Antifungal; Clotrimazole; Complex; Dissolution; Drug; HBenBCD; Hetoconazole; Hydroxybutenyl cyclodextrin; Solubility; Voriconazole

Indexed keywords

COMPLEXATION; CYCLODEXTRINS; DERIVATIVES; DISSOLUTION; ELECTROCHEMISTRY; PH EFFECTS; SOLUBILITY;

ANTIFUNGAL DRUG; CLOTRIMAZOLE; HETOCONAZOLE; STREOCHEMISTRY; VORICONAZOLE;

DRUG PRODUCTS;

ANTIFUNGAL PROPERTY; DISSOLUTION; SOLUBILITY;

EID: 33947683348     PISSN: 09690239     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10570-006-9076-x     Document Type: Article

References (23)

1. Ahmed M.O., El-Gibaly I., Ahmed S.M. (1998). Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Intl. J. Pharm. 171:111-121
2. Buchanan C.M., Alderson S.R., Cleven C.D., Dixon D.W., Ivanyi R., Lambert J.L., Lowman D.W., Offerman R.J., Szejtli J., Szente L. (2002). Synthesis and characterization of water-soluble hydroxybutenyl cyclodextrins. Carbohydrate Res. 327(6):493-507
3. Buchanan C.M., Lambert J.L., Large S.E., Falling S.N., Jicsinszky L., Szejtli J. and Szente L. 2003. Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials. United States Patent 6,610,671
4. Chen T.M., Shen H., Zhu C. (2002). Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. Comb. Chem. High Throughput Screen 5(7):575-581
5. Connors K.A. (1997). The stability of cyclodextrin complexes in solution. Chem. Rev. 97:1325-1357
6. Esclusa-Diaz M.T., Guimaraens-Mendez M., Perez-Marcos M.B., Vila-Jato J.L., Torres-Labanderia J.J. (1996). Characterization and in vitro dissolution behavior of ketoconazole/β- and 2-hydroxypropyl-β-cyclodextrin inclusion compounds. Intl. J. Pharm. 143:203-210
7. Harding D.H. (2003). Pharmaceutical formulations containing voriconazole. United States Patent 6,632,803, B1
8. Higuchi T., Conners K.A. (1965). Phase-solubility techniques. Adv. Anal. Chem. Instr. 4:117-212
9. Owens Paul K., Fell Anthony F., Coleman Michael W. and Berridge John C. 2000. Complexation of voriconazole stereoisomers with neutral and anionic derivatized cyclodextrins. J. Incl. Phenom. Macrocyclic Chem. 38(1-4): 133-151
10. Pan L., Ho Q., Tsutsui K., Takahashi L. (2001). Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. 90(4):521-529
11. Pedersen M., Bjerregaard S., Jacobsen J., Sorensen A.M. (1998). A genuine clotrimazole γ-cyclodextrin inclusion complex-isolation, antimycotic activity, toxicity and an unusual dissolution rate. Intl. J. Pharm. 176:121-131
12. Redenti E., Ventura P., Fronza G., Selva A., Rivara S., Plazzi P.V., Mor M. (1999). Experimental and theoretical analysis of the interaction of (±)-cis-ketoconazole with β-cyclodextrin in the presence of (+)-l-tartaric acid. J. Pharm. Sci. 88:599-607
13. Rotstein D.M., Ketesz D.J., Walker K., Swinney D.C. (1999). Stereoisomers of ketoconazole: Preparation and biological activity. J. Med. Chem. 35:2818-2825
14. Szejtli J. (1991). Cyclodextrins in drug formulations: Part II. Pharm. Technol. 15(8):24-38
15. Szejtli J. (1995). Selectivity/structure correlation in cyclodextrin chemistry. Supramol. Chem. 6:217-223
16. Szejtli J., Szente L., Redenti E. (2000). Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J. Pharm. Sci. 89:1-8
17. Taneri F., Guneri T., Aigner Z., Kata M. (2002). Improvement in the physicochemical properties of ketoconazole through complexation with cyclodextrin derivatives. J. Incl. Phenom. Macrocyclic Chem. 44:257-260
18. Taneri F., Guneri T., Aigner Z., Eroes I. and Kata M. 2003. Improvement of the physicochemical properties of clotrimazole by cyclodextrin complexation. J. Incl. Phenom. Macrocyclic Chem. 46(1-2): 1-13
19. Taneri F., Guneri T., Aigner Z., Berkesi O., Kata M. (2003a). Thermoanalytical studies on complexes of ketoconazole with cyclodextrin derivatives. J. Thermal Anal. Calorim. 74:769-777
20. Taneri F., Guneri T., Aigner Z., Kata M. (2003b). Influence of cyclodextrin complexation on the physiochemical and biopharmaceutical properties of ketoconazole. J. Incl. Phenom. Macrocyclic Chem. 47:15-23
21. Thompson D.O. (1997). Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit. Rev. Therap. Drug Carrier Sys. 14:1-104
22. Uekama K., Hirayama F., Irie T. (1998). Cyclodextrin drug carrier systems. Chem. Rev. 98:2045-2076
23. USP 28-NF 23 711 (2005). The United States Pharmacopeial Convention, Inc., Webcom Limited, Canada 2412-2414